This study investigates pancreatic cancer that cannot be removed surgically. It looks at a new type of radiotherapy combined with chemotherapy.
The purpose of this study is to evaluate the safety and effectiveness of the new treatment. It will also consider the impact on patients' quality of life.
- Who can participate: Adults with pancreatic cancer that cannot be surgically removed and have not received prior radiotherapy may participate if they meet specific health criteria.
- Study details: Participants will receive a single injection of a radioactive implant into the pancreatic tumor.
- Study timelines and visits: The study will last 7 months. The study requires 8 visits.